Predicted expression of genes involved in the thiopurine metabolic pathway and azathioprine discontinuation due to myelotoxicity

被引:4
作者
Daniel, Laura L. [1 ]
Dickson, Alyson L. [1 ]
Zanussi, Jacy T. [1 ]
Miller-Fleming, Tyne W. [1 ]
Straub, Peter S. [1 ]
Wei, Wei-Qi [2 ]
Plummer, W. Dale [3 ]
Dupont, William D. [3 ]
Liu, Ge [1 ]
Anandi, Prathima [1 ]
Reese, Tyler S. [1 ]
Birdwell, Kelly A. [1 ]
Kawai, Vivian K. [1 ]
Hung, Adriana M. [1 ,4 ]
Cox, Nancy J. [1 ]
Feng, QiPing [1 ]
Stein, C. Michael [1 ]
Chung, Cecilia P. [1 ,4 ]
机构
[1] Vanderbilt Univ, Dept Med, Med Ctr, 1211 Med Ctr Dr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Biomed Informat, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Biostat, Med Ctr, Nashville, TN 37232 USA
[4] Tennessee Valley Healthcare Syst, Nashville, VA USA
来源
CTS-CLINICAL AND TRANSLATIONAL SCIENCE | 2022年 / 15卷 / 04期
关键词
ASSOCIATION; TOXICITY;
D O I
10.1111/cts.13243
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
TPMT and NUDT15 variants explain less than 25% of azathioprine-associated myelotoxicity. There are 25 additional genes in the thiopurine pathway that could also contribute to azathioprine myelotoxicity. We hypothesized that among TPMT and NUDT15 normal metabolizers, a score combining the genetically predicted expression of other proteins in the thiopurine pathway would be associated with a higher risk for azathioprine discontinuation due to myelotoxicity. We conducted a retrospective cohort study of new users of azathioprine who were normal TPMT and NUDT15 metabolizers. In 1201 White patients receiving azathioprine for an inflammatory disease, we used relaxed Least Absolute Shrinkage and Selection Operator (LASSO) regression to select genes that built a score for discontinuing azathioprine due to myelotoxicity. The score incorporated the predicted expression of AOX1 and NME1. Patients in the highest score tertile had a higher risk of discontinuing azathioprine compared to those in the lowest tertile (hazard ratio [HR] = 2.15, 95% confidence interval [CI] = 1.11-4.19, p = 0.024). Results remained significant after adjusting for a propensity score, including sex, tertile of calendar year at initial dose, initial dose, age at baseline, indication, prior TPMT testing, and the first 10 principal components of the genetic data (HR = 2.11, 95% CI = 1.08-4.13, p = 0.030). We validated the results in a cohort (N = 517 non-White patients and those receiving azathioprine to prevent transplant rejection) that included all other patients receiving azathioprine (HR = 2.00, (95% CI = 1.09-3.65, p = 0.024). In conclusion, among patients who were TPMT and NUDT15 normal metabolizers, a score combining the predicted expression of AOX1 and NME1 was associated with an increased risk for discontinuing azathioprine due to myelotoxicity.
引用
收藏
页码:859 / 865
页数:7
相关论文
共 30 条
  • [1] [Anonymous], 2021, Stata Statistical Software: Relase 18
  • [2] [Anonymous], 2019, A language and environment for statistical computing
  • [3] Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease[J]. Ansari, A;Hassan, C;Duley, J;Marinaki, A;Shobowale-Bakre, EM;Seed, P;Meenan, J;Yim, A;Sanderson, J. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002(10)
  • [4] The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease[J]. Ban, Hiromistu;Andoh, Akira;Imaeda, Hirotsugu;Kobori, Ayako;Bamba, Shigeki;Tsujikawa, Tomoyuki;Sasaki, Masaya;Saito, Yasuharu;Fujiyama, Yoshihide. JOURNAL OF GASTROENTEROLOGY, 2010(10)
  • [5] Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics[J]. Barbeira, Alvaro N.;Dickinson, Scott P.;Bonazzola, Rodrigo;Zheng, Jiamao;Wheeler, Heather E.;Torres, Jason M.;Torstenson, Eric S.;Shah, Kaanan P.;Garcia, Tzintzuni;Edwards, Todd L.;Stahl, Eli A.;Huckins, Laura M.;Nicolae, Dan L.;Cox, Nancy J.;Im, Hae Kyung. NATURE COMMUNICATIONS, 2018
  • [6] Barbeira AN., 2019, WIDESPREAD DOSE DEPE, V22, P49
  • [7] BONE-MARROW TOXICITY CAUSED BY AZATHIOPRINE IN INFLAMMATORY BOWEL-DISEASE - 27 YEARS OF EXPERIENCE[J]. CONNELL, WR;KAMM, MA;RITCHIE, JK;LENNARDJONES, JE. GUT, 1993(08)
  • [8] Consortium CPI, CPIC GUID THIOP TPMT
  • [9] Next-generation genotype imputation service and methods[J]. Das, Sayantan;Forer, Lukas;Schoenherr, Sebastian;Sidore, Carlo;Locke, Adam E.;Kwong, Alan;Vrieze, Scott I.;Chew, Emily Y.;Levy, Shawn;McGue, Matt;Schlessinger, David;Stambolian, Dwight;Loh, Po-Ru;Iacono, William G.;Swaroop, Anand;Scott, Laura J.;Cucca, Francesco;Kronenberg, Florian;Boehnke, Michael;Abecasis, Goncalo R.;Fuchsberger, Christian. NATURE GENETICS, 2016(10)
  • [10] TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results[J]. Dickson, Alyson L.;Daniel, Laura L.;Zanussi, Jacy;Plummer, W. Dale;Wei, Wei-Qi;Liu, Ge;Reese, Tyler;Anandi, Prathima;Birdwell, Kelly A.;Kawai, Vivian;Cox, Nancy J.;Dupont, William D.;Hung, Adriana M.;Feng, QiPing;Stein, C. Michael;Chung, Cecilia P. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022(01)